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The Norwegian National Council for Priority Setting in Health Care: Decisions and 
Justifications1 
 
Abstract: Different countries have adopted different strategies for tackling the challenge of 
allocating scarce health care resources fairly. Norway is one the countries that has pioneered 
the effort to resolve priority setting by using a core set of priority-setting criteria. While the 
criteria themselves have been subject to extensive debate and numerous revisions, the 
question of how the criteria have been applied in practice has received less attention. In this 
paper, we examine how the criteria feature in the decisions and justifications of the 
Norwegian National Council for Priority Setting in Health Care, which has played an active 
role in deliberating about health care provision and coverage in Norway. We conducted a 
comprehensive document analysis, looking at the Council’s decisions about health care 
allocation as well as the reasons they had provided to justify their decisions. We found that 
although the Council often made use of the official priority-setting criteria, they did so in an 
unsystematic and inconsistent manner.  
 
1. Introduction2 
 
Priority setting in health care is a necessary, but difficult and complex task that can be tackled 
in different ways. Some countries have chosen to address this challenge by adopting a set of 
principles or criteria that are to be applied to a wide range of priority-setting decisions, often 
reflecting broader public debates about what values are relevant for rationing (see e.g. Berg 
and van der Grinten, 2003; Calltorp, 1999; Landwehr and Klinnert, 2015; Rumbold et al, 
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forthcoming). Norway is one of the countries that has spearheaded this approach. Concerted 
efforts have been made from an early stage to take a systematic approach to priority setting, 
and through the work of several national commissions, a set of three official priority-setting 
criteria has been developed, in principle applicable to all kinds of priority-setting decisions 
(Kapiriri et al, 2007; Norheim, 2003) (Table 1).  
 
(Table 1 about here) 
 
While the criteria themselves have been subject to extensive public debate and several 
revisions – most recently in the work of the third Priority Commission and its critics 
(Directorate of Health, 2015; NOU, 2014)3 – questions concerning how the criteria are being 
applied in concrete priority-setting decisions have received less attention. The criteria were 
intended as overarching criteria for priority-setting at all levels of the health care services 
(Directorate of Health, 2012; NOU 1997), and thus it is an important question how and to 
what extent they are being used in practice. In Norway, the National Council for Priority 
Setting in Health Care (‘the Council’) is one of several institutions involved in macro-level 
priority setting in the health care services.4 In this paper, we look at how the Council has 
applied the official priority-setting criteria in deliberating and making decisions about the 
allocation of health care resources. We were interested in firstly, how the criteria were in fact 
being used by the Council, and secondly, whether the Council’s use of the priority-setting 
criteria could shed light on how priority setting happens in practice. For this purpose, we 
examine how the three criteria feature in the Council’s decisions5 and justifications. By means 
of a comprehensive document analysis of all cases processed by the Council from 2007 to 
2014, we examined first, what decisions the Council had made, and second, what reasons they 
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had provided to justify their decisions. In particular, how were the three criteria reflected in 
the justifications they gave, and what other reasons, if any, were offered?  
 
The work of the Council is of interest for a number of reasons. The Council has been active 
since 2007 - and its predecessor since 2002 – but its work is not well known in the 
international debate, in contrast to the work of e.g. NICE (see e.g. Culyer, 2006; Devlin and 
Parker, 2004; Rumbold et al, forthcoming). Within Norway, naturally, the work of the 
Council has received much more attention (e.g. Agenda Kaupang, 2015; Johansson et al, 
2009; NOU, 2014; Ringard et al, 2010; Ringard, Mørland and Larsen, 2012; Ringard, Larsen 
and Norheim, 2012; Wang and Høymork, 2014). However, to date, no systematic analysis has 
been conducted of the Council’s justifications for their decisions, and our paper makes a 
novel contribution in this respect. Furthermore, the Council has made substantial efforts to 
promote transparency in their work. Their recommendations and justifications, as well as all 
case documents and summaries of their deliberations, have been made freely accessible to the 
public via the Council website, and all Council meetings are open for the public to attend. 
This offers a rare opportunity to gain some insight into how they make their decisions.  
 
 
2. The Norwegian National Council for Priority Setting in Health 
Care 
 
The Council was established in 2007 by the Norwegian Ministry of Health and Care Services, 
following the recommendations of the second Priority Commission (NOU, 1997). The 
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Council replaced the earlier National Priority Council, which was active from 2002 to 2006 
(Mørland et al, 2010). In the period from 2007 to 2014, the Council had 25 members, 
representing national and regional health management and administration, the health care 
professions, user and patient organizations and academia. The broad composition of the 
Council is intended to ensure that all important stakeholders and perspectives are represented. 
In addition, the Council has four ex officio members constituting its Secretariat, hosted by the 
Norwegian Knowledge Centre for the Health Services (until 2016).  
 
The Council was intended as an arena for discussing governance and development in quality 
improvement and priority setting in the health services at a national level. Its mandate is to 
help ensure a comprehensive and consistent approach to quality improvement and priority 
setting, by clarifying the roles and responsibilities of different actors in the health care sector 
and improving coordination and interaction between the different levels, such as the primary 
care and specialist services (Mørland et al, 2010; Ringard, Mørland and Larsen, 2012; 
National Health Plan (2007-2010)).6 It is also part of the Council’s mandate to promote public 
debate on the specific cases it deals with as well as on priority setting in health care in general 
(the Council website). 
 
The Council’s primary role is to deliver assessments and recommendations concerning 
priority setting (and up until 2015, quality improvement) in the health care services to health 
management and authorities, policy makers and governing bodies (the Council website; 
Mørland et al, 2010; Ringard, Mørland and Larsen, 2012). These recommendations, however, 
are not binding, but merely advisory. 
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(Table 2 about here) 
 
 
3. Materials and methods 
 
Our analysis covers the Council’s activity between 2007 and 2014. We reviewed all cases 
processed within this period. 
 
Materials 
We reviewed the following documents, all available via the Council’s website: 
- Case documents: case vignettes, case presentation documents, and all supporting 
documents on which the vignette and presentation documents were based 
- Presentations at meetings (available as PowerPoint or PDF files) 
- Meeting minutes, summarising the Council’s discussion 
- Final decisions: The Council’s final assessment, as communicated directly to the 
public on their website, which includes their recommendations and justifications.  
 
Case selection 
The Council website details a number of activities in addition to its recommendations in 
particular priority-setting cases. Such additional content includes, for example, information 
about past and upcoming public meetings and conferences as well as other events related to 
priority setting in the Norwegian health care services. We were only concerned with the 
Council’s actual decisions – thus, it was necessary, first, to identify the subset of cases where 
the Council had issued a recommendation on specific priority-setting questions. Subsequently 
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we completed a thorough review of the selected cases, acquiring detailed knowledge of each 
case and identifying the Council’s justifications for their recommendations. Both authors 
reviewed the cases independently, and subsequently we compared and discussed our findings. 
As discussed in further detail below, it was not always straightforward to identify the basis for 
the conclusion, or the conclusion itself. The independent review of the cases was helpful, as 
was the comparison and discussion of the lists each of us came up with. We were able to 
reach an agreement for each of the cases, but due to the nature of the documents and the 
ambiguity of some of the cases, we cannot guarantee that a third reviewer would have made 
the same assessment in all of the cases. 
 
First, each reviewer identified all cases that concerned coverage of new and existing health 
care treatments and interventions. . Second, we narrowed down this larger set of cases to 
cases where the Council’s final decision contained one or more concrete advisory statements 
regarding coverage of the treatment or intervention in question. For any given case, the 
Council had often issued a range of recommendations, including recommendations for further 
research and quality improvement, but we restricted our analysis to those recommendations 
that specifically concerned coverage. The Council’s engagement with a case tended to be 
fairly broad; thus, it was often not immediately clear whether the Council had set out to 
address specific questions or what these were. Although the case vignette would typically 
highlight key questions for consideration, the Council’s recommendations did not always 
correspond to these questions. The ‘central questions’ listed in Table 3 have been defined by 
‘post hoc’ reconstruction based on the case vignettes, the meeting minutes and the final 
decisions. Recommendations are put forward as part of the Council’s ‘final decision’, a more 
general assessment that sums up key issues and often covers a variety of aspects of the case. 
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However, the recommendations themselves are not always clearly indicated within this 
broader piece of text. Thus, for some of the cases, identifying recommendations required 
some level of interpretation. 
 
Analysis of the Council’s decisions and justifications 
Subsequent to the selection of those cases in which the Council had issued one or more 
concrete recommendations, we sought to identify the reasons the Council had provided in 
support of their recommendation. Justifications, like the recommendations, are also to be 
found in the body of text that constitutes the Council’s final decision. Justifications tended not 
to be stated explicitly or spelled out in detail, and it was not always obvious whether a given 
consideration was specifically intended as a justificatory reason for the recommendation that 
was issued, or whether it was instead included merely as a general observation. Thus, there 
was a certain level of ambiguity with regards to what was intended by the Council as 
justificatory reasons. Some interpretation, therefore, was required for identifying the 
Council’s justifications. 
 
We were primarily interested in the Council’s use of the official priority-setting criteria in 
their justifications, but also registered the use of other supporting reasons. The Council’s 
references to the three priority-setting criteria varied somewhat with respect to how direct or 
explicit they were, and we distinguish between ‘direct’ and ‘indirect’ references to each of the 
criteria. ‘Direct’ references include all explicit mentioning of a criterion, as well as quite 
specific references to the content of the criterion, but without specifically naming the criterion 
itself. For example, we considered a statement such as ‘The costs are high, but not sufficiently 
so to count against inclusion of the vaccine’ (HPV vaccine) as a reference to the cost-
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effectiveness criterion, even if it is not specifically stated that the cost-effectiveness criterion 
is met. Similarly, we considered statements about poor prognosis and high morbidity and 
mortality (Left ventricular assist device) as direct references to the severity criterion. 
Statements about the level or quality of evidence of effectiveness were considered direct 
references to the expected benefit criterion.  In three of the cases, the Council made reference 
to factors that would impact on whether the Expected benefit criterion is met, even if that 
factor is not directly contained in the criterion itself. For example, the possibility of false 
positives was offered as a justifying reason in Genetic testing, and risk of complications was 
mentioned in both Screening for colorectal cancer and Surgical treatment of obesity. We 
included these justifying reasons as ‘indirect’ references to the Expected benefit criterion. 
Finally, reasons offered in support of the Council’s decisions with no clear relation to the 
official priority-setting criteria were recorded as ‘other’ reasons. We included references to 
the WHO criteria for screening in this category. These criteria – ten in total – include 
significance of the health problem, availability of effective treatment and costs (Wilson and 
Jungner 1968), and as such one could say that there is some overlap between the WHO 
criteria and  the official priority-setting criteria. However, as the Council did not specify 
which of the ten WHO criteria they had in mind, we counted their references to the WHO 
criteria as a reference to ‘other’ justifications. 
 
For each case, we also considered whether the Council’s decision and justification complied 
with the official priority-setting criteria. Here, we conducted an in depth analysis of the 
background information for the case and the Council’s deliberations as per the meeting 
minutes. Thus we aimed to determine first, to what extent the Council had taken a position on 
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whether each of the three criteria had been met, and second, whether their final decision was 
in accordance with that position. 
 
Finally, we considered whether there were any trends across time with respect to the 
Council’s use of the criteria. 
 
4. Results 
 
Cases 
We identified 187 cases that met our selection criteria, out of a total of 105 cases processed 
between 2007 and 2014. The selected cases with decisions and justifications are presented in 
table 3. 
 
(Table 3 about here) 
 
The number of cases with one or more clearly identifiable and concrete advisory statements 
on health care coverage was fairly low. As described above, many of the Council’s cases 
concerned quality improvement or were merely intended for general discussion. Nevertheless, 
it is noteworthy that we had to exclude several cases from our analysis because the 
recommendation was too general or vague, or because it was simply unclear whether a 
recommendation had been made.  
 
The Council’s use of the official priority-setting criteria 
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The Council had provided a justification for their recommendation in 15 of the 18 cases – the 
remaining three cases lacked a justification. The Council made reference to the official 
priority-setting criteria in their justification in 12 of these cases (the Council’s use of the 
criteria is summarised in table 4). However, the Council generally only referred to one or two 
of the criteria, rather than using all of the criteria together. Furthermore, in some of the cases 
where the Council had made reference to a criterion in their justification, it was not clear 
whether they thought the criterion had been met. The Expected benefit criterion was used the 
most, appearing in eight cases, while the Cost-effectiveness criterion was used in seven cases. 
The Severity criterion was used the least, cited in only five cases. We did not detect any 
pattern in the Council’s use of the criteria over time. 
 
(Table 4 here) 
 
Insofar as the Council had referred to each of the three official priority-setting criteria, their 
recommendations were usually in accordance with the criteria. Two recommendations were 
justified on the grounds that two of the criteria had been met (Smoking cessation, HPV 
vaccine). Conversely, several recommendations against the inclusion of a treatment or 
intervention were justified on the grounds that one or more of the criteria had either not been 
met (Cochlear implants, Rotavirus vaccine, Screening for postnatal depression), or that there 
was insufficient documentation thereof (Heart valves, Left ventricular assist device (2008), 
Genetic testing). 
 
However, there were some noteworthy exceptions to this general pattern. In the first cluster of 
exceptions, the Council made recommendations that were arguably in conflict with their own 
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judgment concerning one or more of the three criteria, with no clear explanation or 
justification offered for the departure from the criteria. In Early ultrasound, the Council’s 
preliminary decision indicated that there were no grounds for expecting early ultrasound to 
yield any medical benefits for either the mother or the foetus – it seems, then, that they took 
the view that the Expected benefit criterion had not been met. Nevertheless, in their final 
decision, the Council made a recommendation in favour of the introduction of early 
ultrasound screening. The preliminary decision and the discussion indicate that the Council 
believed that other concerns beyond the official priority-setting criteria – in particular, early 
diagnosis of Down’s syndrome, as well as social inequalities in access to services – might be 
relevant for evaluating the introduction of early ultrasound. But this is not made explicit, nor 
is there any record of a discussion of whether such other concerns are sufficiently weighty to 
justify an exception to the official priority-setting criteria. . In Climate therapy abroad, the 
Council recommended that the scheme should be continued. However, their discussion of the 
case indicates that there was great uncertainty concerning both effectiveness and cost-
effectiveness. Yet, no explicit justification was provided for continuing the scheme in spite of 
such uncertainty, beyond an emphasis on the need for further research to assess the effects 
and the costs of this treatment.  
 
In the second cluster of exceptions, the Council’s decision was mixed, allowing for 
exceptions to their general recommendation subject to individual assessment by health care 
professionals. However, they did not offer any reasons for why such exceptions should be 
allowed, even though the exceptions seemed to violate one or more of the official priority-
setting criteria. In Long-term mechanical ventilation, the Council states explicitly that this 
intervention ‘does not meet the priority-setting criteria’. It was clear from the Council’s 
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discussion that they considered the costs to be well above any reasonable cost-effectiveness 
threshold. (The discussion suggests that they also had severe doubts about whether the 
expected benefit criterion had been met, but it is unclear what position they took on this point 
in the end). Similarly, in Cochlear implants, the high costs relative to the expected benefit 
was the stated reason for not granting a right to a second implant. In both cases, it is unclear 
on what grounds they recommended that the intervention should nevertheless be available to 
selected patients. The Surgical treatment of obesity case also bore some resemblance to these 
two cases, in that there seemed to be some incongruence between one part of the 
recommendation and the considerations they raise in relation to the expected benefit criterion. 
The Council recommended prioritizing non-surgical interventions, apparently on the basis of 
uncertainty concerning the long term effects and the high risks of side effects of surgery, but 
nevertheless they also recommended against restricting eligibility for such surgery. No further 
reasons were given to explain the basis for this latter part of their decision. 
 
The Council sometimes made reference to other kinds of considerations in their final decision. 
These included: international guidelines; the lack of an alternative intervention or treatment; 
fear in the population; the importance of preventive interventions; reduce social inequalities in 
health; total budgetary implications; treatment already in use; public trust in the health care 
services; the WHO screening criteria. Often, where such other considerations had been 
emphasised, they were offered as further but secondary support for a recommendation based 
on one or more of the official priority-setting criteria, though there were some exceptions. In 
Breast reconstruction surgery, Left ventricular assist device and Monoclonal antibodies, the 
appeal to other considerations appear to have been made in order to support a 
recommendation where the recommendation’s compliance with the official priority-setting 
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criteria was not clear-cut, though this was not made explicit. In Breast reconstruction surgery, 
the Council made a recommendation that, effectively, gave higher priority to this intervention 
than under the status quo.8 However, the rationale for this decision was unclear. The Council 
noted that the costs are very high and that the evidence base for expected benefit and costs 
should be strengthened, but it is not clear from their discussion or final decision what 
conclusion they reached with respect to either expected benefit or cost-effectiveness. 
Although they referred to ‘international guidelines’ as an alternative justification, they did not 
explain why this particular consideration should be given weight in this instance. In the 
reconsideration of the Left ventricular assist device case in 2013, the Council concluded that 
the intervention should be offered to carefully selected patients, in light of somewhat better 
evidence of clinical effectiveness. The Council acknowledged that the costs of the 
intervention were high and that cost-effectiveness was low, but it also pointed out that 
eligibility for the treatment was likely to be limited to only eight to twelve patients per year. 
Although this observation is not explicitly offered as a justificatory reason, it is possible to 
read the statement as a claim about low overall costs or budgetary implications, which may 
have been intended as a reason justifying ‘overriding’ the cost-effectiveness criterion. In 
Monoclonal antibodies, the Council gave a ‘conditional approval’ of the treatment, 
recommending that it be made available to patients within a clinical phase IV study. Their 
main concern was the high costs of these drugs, and this appears to have been the reason for 
their recommendation against the inclusion of these drugs in the standard treatment protocol. 
Two reasons are offered that, like in the Left ventricular assist device case, can be read as 
reasons that justify overriding the cost-effectiveness criterion: Firstly, the drugs were already 
in use, and secondly, availability of the drug via a clinical phase IV study would not entail an 
increase in general health expenditures. 
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5. Discussion 
 
The Council issued concrete recommendations in a fairly low number of cases. The tendency 
to issue advisory statements of a more general nature was also noted by the Kaupang report 
and the third national Priority Commission in their evaluations of the Council’s work (Agenda 
Kaupang, 2015; NOU, 2014). Both reports emphasised the need for more specific and 
concrete advice. The Kaupang report suggested that the Council’s consensus based approach 
might partly explain this feature of the Council’s recommendations, which seems plausible: 
the more specific and concrete the recommendation, the more scope for disagreement. In 
particular, this seems likely given the Council’s broad composition, with members 
representing different stakeholders in health care and a diverse and sometimes conflicting set 
of interests and perspectives. In this context, where it may be difficult to reach an agreement, 
a consensus based approach may serve as a disincentive to issuing more concrete 
recommendations. Recommendations that in a sense deferred part of the decision-making to 
other parties can also be seen in this light: allowing some level of flexibility in the decision, as 
opposed to being absolute – e.g. by giving a mixed recommendation or allowing for 
individual exceptions – might also increase the likelihood of obtaining a consensus. 
Alternatively, a concern to preserve some degree of local autonomy may also have motivated 
less absolute decisions. 
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While the Council often appealed to the official priority-setting criteria to justify their 
recommendations, they did not do so in a systematic or consistent manner.. Firstly, in six out 
of 18 cases, the Council made no explicit reference to any of the official priority-setting 
criteria in their final decision. Secondly, the Council did not use all three criteria together, but 
referred to only one or two at a time, without explaining why they employed some of the 
criteria but not others. Importantly, the three criteria should have been used together, 
according to the recommendations of the second Priority Commission (NOU 1997) and the 
relevant legislation in effect at the time. In some of the cases, the failure to refer to one or 
more of the criteria seemed to have been ‘innocent’, in the sense that whether or not the 
omitted criterion had been met was considered self-evident or uncontroversial, and 
compliance with it thus implicitly assumed. In particular, this often seems to have been the 
case for the Severity criterion (e.g. Genetic testing, Heart valves) – we can reasonably expect 
to find more discussion of this criterion in cases where a condition’s level of severity was not 
clear-cut. In other cases, however, it was simply not clear why some of the criteria had not 
been cited, nor was it always possible to deduce from the Council’s deliberation what their 
stance was with regards to the criteria that were not mentioned in their final decision. Thirdly, 
there were also several cases where recommendations and justifications were mixed in terms 
of their compliance with the criteria, without the Council giving explicit reasons for their 
departure from the criteria. There are reasons to be concerned about the lack of a systematic 
and principled approach to the use of the criteria 
 
We suggest that two sets of factors may help explain the unsystematic, and to some extent 
inconsistent use of the criteria in the Council’s decisions and justifications. Firstly, the criteria 
themselves may not always provide adequate support for decision-making. Secondly, certain 
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features of the Council may influence their decision-making process and its outcomes. We 
consider each in more detail below. 
 
The official priority-setting criteria have been widely endorsed and have been attempted 
implemented in the health care services in various ways. At the same time, however, it has 
been pointed out that the criteria have been difficult to apply in practice (NOU, 2014; Wisløff, 
2015). One important concern in that respect is the discretionary nature of the official 
priority-setting criteria, which arguably imposes some limitations on the level of decision 
support that they provide. Neither of the criteria has been formulated in very precise or 
concrete terms, and thus require significant discretionary judgement: ‘Not insignificant’, 
‘expected to benefit’ and ‘reasonable ratio of costs to benefits’ are all statements with 
considerable interpretative space. In particular, the severity criterion allows for a wide range 
of possible interpretations (see Robberstad 2015). Thus, in some cases it may be difficult to 
reach an agreement on whether the criteria have been met; accordingly, an advisor or 
decision-maker might be hesitant to attribute much weight to this consideration in reaching a 
decision. Conversely, however, a criterion that is formulated in less precise terms may be 
marshalled ad hoc to support a wide range of decisions. A further issue is how the criteria 
should be weighed against each other in cases where they conflict. To a large extent, this 
question was left open by the second Priority Commission – their discussion highlights 
important challenges but is not conclusive, and they allowed that different weights may be 
assigned to the criteria depending on the objective of the evaluation (NOU 1997).9 
 
To some extent, the Council’s deliberations reflect some level of difficulty in applying the 
criteria. First, in the Breast reconstruction surgery case, the question of how the severity 
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criterion should be interpreted in relation to this group of patients came up in the discussion – 
more specifically, how much weight should be attributed to concerns about quality of life in 
the evaluation.  Second, the Climate therapy abroad case featured a discussion of the 
application of the expected benefit criterion, and of whether the benefits of the intervention 
were sufficient to meet the criterion.It is not clear from the discussion what, if any, 
conclusions were reached in each case, and the Council made no reference to these criteria in 
the final decision. At the same time, however, potential difficulties in applying the criteria 
does not explain why, in some cases, the Council did not consider the criteria at all. 
 
The second set of factors concerns certain features of the Council itself. One important 
consideration is the formal status of the Council. The Council’s role is primarily advisory, and 
the health authorities and other governing bodies are under no obligation to abide by the 
Council’s recommendations. Thus, it is somewhat unclear how one might characterise the 
status and implications of the Council’s final decisions. We suggest that this lack of formal 
decision power may be part of the explanation for the Council’s lack of a systematic and 
principled approach to arriving at, and justifying, their decisions. The need for accountability, 
through for example clear and detailed explanations of the rationale behind decisions, may 
seem less pressing when the decisions are ‘merely’ advisory, and the responsibility for 
making a decision lies elsewhere. A further concern is the composition of the Council and its 
internal dynamic. As we have already remarked upon, the members of the Council are 
selected to represent different stakeholders in health care, with diverse and sometimes 
conflicting sets of interests. On the one hand, this approach ensures that a range of 
perspectives will be represented and may be an effective means to promote debate, which is 
part of the Council’s mandate. But on the other hand, insofar as members are prone to act as 
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advocates of their stakeholder group’s interests, conflicting interests will likely make reaching 
an agreement more difficult.10 Furthermore, as Landwehr and Klinnert (2015) have suggested, 
different parties – e.g. health economists versus patient representatives – may represent 
different values, which in turn will likely affect how much weight they attribute to 
considerations such as cost-effectiveness. 
 
It is beyond the scope of this paper to consider in further detail the extent to which different 
kinds of institutional properties and practices may promote or hinder good decision-making. 
Here, we merely wish to point to the possibility that such factors play a role in how an 
institution like the Council makes its decisions, and to suggest that this question merits further 
discussion and research. 
 
Lastly, we offer a few observations regarding our finding that the Council referred to a wide 
range of considerations other than the official priority-setting criteria in support of their 
recommendations (see also Wang and Høymork (2014) on this point).  
It is notable the Council was not explicit about what role these other considerations played in 
their deliberation. Furthermore, they did not provide any details about their procedure for 
deciding when and why other considerations were relevant. Finally, no details were given 
about how these other considerations were weighed relative to the official priority-setting 
criteria in reaching a decision. Clearly, further discussion is needed about the appropriate 
procedure for identifying and incorporating other morally relevant concerns. 
 
  
6. Conclusion 
19 
 
19 
 
 
In this paper, we examined the Priority Council’s coverage decisions and the reasons they 
provided to justify these decisions, with a particular focus on the extent to which their 
justifications reflected the official priority-setting criteria. While for the most part, the criteria 
seemed to have played an important role in the Council’s decisions and justifications, it was 
also evident that they did not always apply the criteria in a systematic and principled manner. 
 
We suggested that these findings may in part be explained by a combination of factors, 
including the discretionary nature of the three criteria, the Council’s lack of formal decision-
making power, as well as the compositions of its members and their dynamic. In particular, 
the latter two point towards a more general lesson. The international academic debate on 
priority setting in health care tends to focus either on what criteria, principles or values should 
inform our decisions, or on defining fair decision-making procedures. Our study of the 
Norwegian National Council suggests that we ought to pay more attention to the appointed 
institutions that are tasked with making priority-setting decisions. Whether such institutions 
rely on substantive criteria or fair procedures, their role, design and structure may influence 
the decisions that are being made. The question of how priority-setting institutions should be 
designed in order to foster good decision-making deserves a more prominent place in the 
debate on the fair allocation of health care resources. 
1 Author 1 has no prior or current engagement with the Council. Author 2 was previously in the Secretariat of the 
first Priority Council, from 2002 to 2006. 
2 Acknowledgements withheld to preserve anonymity. 
3 For a commentary on these revisions, see Bringedal (2015). 
4 Designated priority-setting institutions and agencies can also be found in other countries, e.g. Canada (the 
Canadian Agency for Drugs and Technologies in Health), Germany (Institut für Qualität und Wirtschaftlichkeit 
im Gesundheitswesen and Gemeinsamer Bundesausschuss), France (Haute Autorité de Santé), the UK (the 
National Institute for Health and Care Excellence) and Sweden (Prioriteringscentrum). The role that such bodies 
play and their level of responsibility vary. 
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5 The Council’s decisions are perhaps more accurately characterised as recommendations and assessments, as 
their recommendations are not binding, and the final decision-making authority lies with policy makers and 
governing bodies. Nevertheless, for the sake of simplicity, we will refer to the Council’s issued statements as 
‘decisions’. 
6 In the course of the Council’s existence it has undergone several changes to its mandate. One of the more 
substantial changes is the narrowing of the mandate from dealing with issues concerning both quality and 
priority setting in the health services to focusing only on the latter. This change was implemented in 2015 and 
thus does not affect our analysis, which covers the work of the Council in the period from 2007 to 2014. 
7 One of the cases, Left Ventricular Assist Device, was handled twice, in 2008 and in 2013, when the Council 
revised their earlier position. We count this as one case, but consider the different justifications they provided 
separately. 
8 The implication of including reconstructive surgery in the treatment plan for breast cancer is that patients will 
have a right to an assessment for such surgery in accordance with the Patient Rights Act, which in practical 
terms means that the patient will be seen sooner. 
9 Because of these and related issues regarding the application of the criteria, reviewing the criteria was a central 
task for the third Priority Commission. Their recommended revisions to the criteria sought to address these 
concerns (NOU, 2014). 
10 In fact, that this kind of dynamic was often an issue in the Council’s discussions was suggested to us by one 
previous member of the Council (Bjarne Robberstad, in conversation). Unfortunately, this very interesting issue 
lies beyond the scope of what our document analysis can address. 
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Tables 
Table 1. The three official priority-setting criteria 
The three official priority-setting criteria: 
 
Severity of health state  as determined by prognosis for loss of life, 
diminished physical or mental functioning, and pain 
Expected benefit of treatment  as determined by increased probability of survival, 
improved physical or mental functioning, and 
reduced pain 
Cost-effectiveness of treatment  the costs should stand in a reasonable relation to the 
benefits of the treatment 
 
(NOU, 1997; Norheim, 2003) 
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The criteria are to be applied together, such that a treatment must meet all three criteria in order to be given 
priority. The criteria were intended as overarching criteria for priority-setting at all levels of the health care 
services (Directorate of Health, 2012; NOU 1997), and are reflected both in legislation and in practice in 
various ways. Importantly, until 2015, the criteria were codified in the Patient Rights Act (LOV-1999-07-02-
63) and its section 2.1b, Regulation on Priority Setting (FOR-2000-12-01-1208). This law grants patients a 
right to health care, provided that the health condition is severe and that the costs of treatment are ‘reasonable’ 
relative to the expected benefit. The criteria are also embedded in the Regulation on Medicines (FOR-2010-
06-23-957), which governs the evaluation of new drugs for inclusion in the prescription reimbursement 
scheme (NOU, 2014; Wisløff, 2015). 
 
 
 
Table 2. The Council’s case procedure 
Case submission As of 2011, the Council operates with an open 
submission policy whereby anyone, including the 
public, can propose a case. Prior to this policy, case 
proposals could only be submitted by the Department 
of Health, Council members and the Secretariat. 
Preliminary assessment and selection of cases  The Secretariat reviews submitted proposals. In 
principle, the Secretariat may refuse proposals that 
are deemed not relevant for the Council’s work. But 
granted that a case meets this minimum requirement, 
the Secretariat will conduct a preliminary assessment 
of the case, together with the proposer, intended to 
give a broad overview of relevant information and 
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highlight key issues. This assessment, presented in a 
case vignette, informs the Council’s decision about 
whether to proceed with the case. 
Comprehensive assessment and case presentation  If the Council accepts a case, the Secretariat and the 
proposer will proceed to conduct a more thorough 
assessment. This assessment covers a wide range of 
available information, including systematic reviews 
and health technology assessments conducted by the 
Norwegian Knowledge Centre for the Health 
Services, as well as other kinds of evaluations 
delivered by other independent research 
organisations. The Secretariat will also typically 
identify and provide background information on 
other aspects of the case, such as whether a 
treatment’s compliance with the official priority-
setting criteria has been evaluated, various ethical 
issues, the patient perspective, and the Council’s or 
other parties’ previous treatment of similar cases. The 
Secretariat will consult a wide range of sources, 
including resource and knowledge centres, health 
care professionals and specialists, user and patient 
organisations, ethicists, and health management. The 
assessment is summarised in a case presentation 
document, which is distributed to members of the 
Council, along with the reports and evaluations on 
which it is based. 
Deliberation and decision  The Council members will discuss the case and reach 
a decision in the course of one or more Council 
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meetings. Meetings will also typically involve 
presentations by experts in the field and occasionally 
representatives from user and patient organisations. 
The Council is explicit in endorsing a consensus-
based approach. If a consensus cannot be obtained, 
members will vote in order to make a final decision. 
(The Council website) 
 
 
 
 
 
Table 3. Case summaries and decisions 
Case Year Central 
question 
Recommendation Justification 
Official priority-setting criteria Other 
justificatory 
reasons 
Direct Indirect 
Cochlear 
implants 
 
2007 Should a 
second 
implant for 
adults qualify 
as ‘necessary 
health care’ 
under the 
Patient Rights 
Act? 
As a general rule, 
patients should 
have a right to 
one but not two 
cochlear 
implants. A 
second implant 
may be granted 
subject to 
individual 
assessment, (‘on 
the basis of the 
Regulation on 
Priority 
Setting’). 
Many individuals 
could benefit 
from a second 
implant, but the 
costs are too high 
relative to the 
benefit to grant a 
right. 
  
Heart valves 
 
2008 Should 
catheter-based 
implantation 
of heart 
Catheter-based 
implantation of 
heart valves 
should not be 
On the basis of 
available 
evidence, the 
treatment is 
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valves be 
offered in 
Norway?  
offered to 
patients in 
Norway at this 
time. 
considered 
experimental. 
HPV vaccine 
 
2008 Should the 
HPV vaccine 
be included in 
the children’s 
national 
vaccination 
programme? 
The HPV 
vaccine should 
be offered as part 
of the children’s 
national 
vaccination 
programme. 
There is 
reasonable 
certainty that the 
vaccine is 
effective. The 
costs are high, 
but not 
sufficiently so to 
count against 
inclusion of the 
vaccine.  
 The Council 
emphasises that 
the intervention 
is preventive. 
The Council 
emphasises that 
including the 
vaccine in the 
national 
programme 
could help 
reduce social 
inequalities in 
health. 
Left 
ventricular 
assist device 
2008 
 
Should a left 
ventricular 
assist device 
(mechanical 
heart pump) 
be offered to 
patients, 
either as a 
temporary 
solution or as 
a permanent 
solution 
(instead of 
transplant)? 
Patients with 
severe final 
stage heart 
failure. 
The heart pump 
should only be 
offered as a 
temporary 
solution for 
patients awaiting 
a transplant. It 
should not 
replace heart 
transplants as the 
preferred long-
term treatment 
for this patient 
group. 
This patient 
group has a very 
poor prognosis. 
The clinical 
effectiveness of 
the treatment is 
not sufficiently 
documented, 
and it is 
considered 
investigational. 
The costs are 
considerable, 
but it is 
currently not 
possible to 
establish 
whether they are 
reasonable 
compared to the 
benefits. 
  
Monoclonal 
antibodies 
 
2008 Should 
monoclonal 
antibodies be 
included in 
the standard 
treatment of 
metastatic 
colorectal 
cancer? 
The medication 
should be offered 
to patients as part 
of a clinical 
phase IV trial. 
Metastatic 
colorectal 
cancer is a 
severe 
disease with 
high 
mortality. 
The costs of 
the treatment 
are high.  
 Monoclonal 
antibodies are 
already in use as 
first and third 
line treatment. 
The decision 
does not involve 
an increase in 
general health 
care 
expenditure. 
Newborn 
screening 
 
2008 Should the 
current 
programme 
be expanded 
to include 
screening for 
an additional 
The Council 
supports the 
recommendation 
of the Directorate 
of Health 
initiated work 
group to expand 
  The work group 
concluded that 
screening for 
these conditions 
complied with 
the WHO 
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21 rare 
congenital 
metabolic 
disorders? 
the screening 
programme. 
criteria for 
screening.10 
Genetic 
testing 
 
2009 Should all 
women with 
recently 
diagnosed 
breast or 
ovary cancer 
be offered 
genetic 
testing, even 
in the absence 
of a family 
history of 
cancer? 
Genetic testing 
should only be 
offered subject to 
risk assessment, 
in particular 
family history of 
cancer. 
There was 
disagreement on 
whether the 
effectiveness of 
testing of 
women without 
a family history 
of cancer was 
sufficiently well 
documented.  
There was 
uncertainty 
regarding 
how many 
false 
positives 
would 
result in 
mastectomy 
or 
hysterectom
y. 
 
Breast 
reconstruction 
surgery 
2010 Should 
consideration 
for 
reconstructive 
breast surgery 
by individual 
assessment be 
included in 
the treatment 
plans for 
breast cancer? 
Consideration for 
reconstructive 
surgery should 
be part of the 
treatment options 
offered to breast 
cancer patients. 
  The Council 
makes their 
recommendatio
n ‘on the basis 
of international 
guidelines’. 
Screening for 
colorectal 
cancer 
 
2010 Should 
Norway 
establish a 
national 
screening 
programme 
for colorectal 
cancer? 
The Council 
recommends a 
‘cautious 
approach’. In the 
first instance, 
screening for 
colorectal cancer 
should only be 
offered to 
selected groups 
as part of a pilot 
study.  
Colorectal 
cancer is a 
major public 
health issue 
with high 
morbidity 
and mortality. 
Screening is 
the only 
intervention 
known to 
reduce 
morbidity 
and mortality.  
Further 
examinations 
subsequent to 
positive testing 
may give rise 
to 
complications. 
Screening could 
give rise to fear 
in the 
population.  
Early 
ultrasound 
 
2011 Should early 
ultrasound 
scans (week 
11-13) be 
included as 
part of routine 
antenatal 
examinations? 
Routine 
ultrasound 
should be offered 
in weeks 11-13 
and 17-19. 
   
Smoking 
cessation 
 
2011 Should 
smoking 
cessation aids 
be offered by 
the health 
care services? 
What can be 
The municipal 
health care 
services and the 
GPs should 
improve and 
systematise the 
smoking 
Smoking 
cessation aids 
are effective 
and cost-
effective. 
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done to 
improve the 
quality and 
scope of 
smoking 
cessation 
assistance 
offered via 
the health 
care services? 
cessation aids 
that they offer. 
The Regulation 
on Medicines 
should be 
modified to 
enable free 
prescription of 
smoking 
cessation 
medication. 
Rotavirus 
vaccine 
 
2012 Should the 
rotavirus 
vaccine be 
included in 
the national 
children’s 
vaccination 
programme? 
The vaccine 
should not be 
included in the 
national 
vaccination 
programme. 
Rotavirus 
infection is 
not 
considered a 
severe 
disease.  
 To ensure the 
public’s support 
of the 
vaccination 
programme, the 
public must 
have faith in the 
necessity of 
vaccination for 
the prevention 
of severe 
disease. 
Climate 
therapy 
abroad 
 
2013 Should the 
climate 
therapy 
abroad 
scheme for 
patients with 
chronic 
disease be 
continued? 
Should this 
scheme be 
extended to 
more 
patients? 
The scheme 
should be 
continued in its 
current form. 
Which groups 
should be 
eligible for the 
scheme needs to 
be reconsidered. 
   
Left 
ventricular 
assist device 
2013 Should a left 
ventricular 
assist device 
(mechanical 
heart pump) 
be offered to 
patients as a 
permanent 
solution? 
The heart pump 
should be offered 
as a permanent 
solution to 
carefully selected 
patients who do 
not meet the 
eligibility criteria 
for a heart 
transplant. 
The heart 
pump could 
enhance 
survival and 
improve 
quality of life 
for carefully 
selected 
patients. [] 
The Council 
expects 
reduced costs 
and improved 
clinical 
effectiveness 
with time. 
  
Screening for 
cervical 
cancer 
 
2013 Should the 
method for 
screening for 
cervical 
The HPV test 
should be piloted 
in the Norwegian 
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cancer be 
changed, by 
testing for 
HPV virus 
infection in 
addition to the 
standard 
smear test? 
health care 
services. 
Screening for 
postnatal 
depression 
 
2013 Should 
screening for 
postnatal 
depression 
with the 
Edinburgh 
Postnatal 
Depression 
Scale (EPDS) 
be routinely 
offered in 
Norway?  
Screening for 
postnatal 
depression 
should not be 
routinely offered 
at this time. 
  Screening with 
the EPDS does 
not meet the 
WHO criteria 
for screening. 
Long-term 
mechanical 
ventilation 
 
2014 Does long-
term 
mechanical 
ventilation for 
patients with 
amyotrophic 
lateral 
sclerosis meet 
the priority-
setting 
criteria? 
Long-term 
mechanical 
ventilation does 
not meet the 
priority-setting 
criteria. This 
treatment option 
should only be 
offered to 
especially 
motivated 
patients and after 
thorough 
assessment. 
Long-term 
mechanical 
ventilation does 
not meet the 
priority-setting 
criteria. 
  
Surgical 
treatment of 
obesity 
2014 Should action 
be taken to 
curb the 
increase in 
surgical 
treatment of 
obesity? 
Non-surgical 
interventions 
against obesity 
should be given 
higher priority. 
The Council 
recommends 
against 
restricting 
eligibility for 
surgery at this 
time. 
Obesity is a 
severe 
condition. 
Surgical 
treatment 
results in 
significant 
and rapid 
weight loss.  
Long term 
effects on 
morbidity 
and quality of 
life are not 
well known. 
Risks of 
complications 
and side 
effects are 
substantial. 
Surgery 
commonly 
requires 
lifelong follow 
up by the 
health care 
services. 
 
 
The wording of the recommendations and justifications has been kept as close as possible to the Council’s own, 
but are not direct citations unless otherwise indicated. The central question is reconstructed on the basis of case 
vignettes, meeting minutes and the final decision. 
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Table 4. Summary of the Council’s use of the official priority-setting criteria 
Case Recommendation Use of priority criteria 
Criterion Is the criterion met 
Cochlear implants Mixed Expected benefit  
Cost-effectiveness 
Yes 
No 
Heart valves Rejection Expected benefit No 
HPV vaccine Approval Expected benefit 
Cost-effectiveness  
Yes 
Yes 
Left ventricular assist device 
(2008) 
Rejection Severity 
Expected benefit Cost-
effectiveness 
Yes 
No 
No 
Monoclonal antibodies Treatment available to 
selected patients as part of 
research 
Severity 
Cost-effectiveness 
Yes 
? 
Newborn screening Approval  
Genetic testing Rejection Expected benefit       ? 
Breast reconstruction surgery Approval  
Screening for colorectal 
cancer 
Treatment available to 
selected patients as part of 
research 
Severity 
Expected benefit 
Yes 
? 
Early ultrasound Approval  
Smoking cessation Approval Expected benefit  
Cost-effectiveness 
Yes 
Yes 
Rotavirus vaccine Rejection Severity No 
Climate therapy abroad Approval  
Left ventricular assist device 
(2013) 
Approval Expected benefit 
Cost-effectiveness 
Yes 
? 
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Screening for cervical cancer Treatment available to 
selected patients as part of 
research 
 
Screening for postnatal 
depression 
Rejection  
Long-term mechanical 
ventilation 
Mixed Cost-effectiveness No 
Surgical treatment of obesity Mixed Severity 
Expected benefit 
Yes 
? 
 
? : It is unclear what the Council concluded regarding whether the criterion was met.  
 
 
 
